Page 134 - Read Online

Calvo et al. Omega-3 fatty acids in cardiovascular health

78. Watanabe M, Uesugi M. Small-molecule inhibitors of SREBP Omega-3 fatty acids improve glucose tolerance and components of the
activation - potential for new treatment of metabolic disorders. Med metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project.
Chem Comm 2013;4:1422-33. Int J Circumpolar Health 2005;64:396-408.
79. Dentin R, Benhamed F, Pégorier JP, Foufelle F, Viollet B, Vaulont 96. Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen
S, Girard J, Postic C. Polyunsaturated fatty acids suppress glycolytic E, Riccardi G, Rivellese AA, Tapsell L, Hermansen K; KANWU
and lipogenic genes through the inhibition of ChREBP nuclear protein Study Group. Effects of dietary saturated, monounsaturated, and
translocation. J Clin Invest 2005;115:2843-54. n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr
80. Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, 2006;83:221-6.
Schwertfeger G, Bedynek A, Shepherd J, Seidel D. Apolipoprotein 97. Cabo J, Alonso R, Mata P. Omega-3 fatty acids and blood pressure. Br
B metabolism and the distribution of VLDL and LDL subfractions. J J Nutr 2012;107 Suppl 2:S195-200.
Lipid Res 2000;41:305-18. 98. Ulu A, Harris TR, Morisseau C, Miyabe C, Inoue H, Schuster G, Dong
81. Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks H, Iosif AM, Liu J, Weiss RH, Chiamvimonvat N, Imig JD, Hammock
JD, Williams KJ. The triple threat to nascent apolipoprotein B. BD. Anti-inflammatory effects of omega-3 polyunsaturated fatty acids
Evidence for multiple, distinct degradative pathways. J Biol Chem and soluble epoxide hydrolase inhibitors in angiotensin-II dependent
2001;276:27855-63. hypertension. J Cardiovasc Pharmacol 2013;62:285.
82. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, 99. Shao Z, Fu Z, Stahl A, Joyal JS, Hatton C, Juan A, Hurst C, Evans
Fisher EA. Lipid peroxidation and oxidant stress regulate hepatic L, Cui Z, Pei D, Gong Y, Xu D, Tian K, Bogardus H, Edin ML, Lih
apolipoprotein B degradation and VLDL production. J Clin Invest F, Sapieha P, Chen J, Panigrahy D, Hellstrom A, Zeldin DC, Smith
2004;113:1277-87. LE. Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid
83. Jacobson TA, Glickstein SB, Rowe JD, Soni PN. Effects of metabolites increase mouse retinal pathologic neovascularization--
eicosapentaenoic acid and docosahexaenoic acid on low-density brief report. Arterioscler Thromb Vasc Biol 2014;34:581-6.
lipoprotein cholesterol and other lipids: a review. J Clin Lipidol 100. Agbor LN, Wiest EF, Rothe M, Schunck WH, Walker MK. Role
2012;6:5-18. of CYP1A1 in modulating the vascular and blood pressure benefits
84. Maggi F, Sirtori CR, Baldassarre D, Rise P, Galli C. Correlations of of omega-3 polyunsaturated fatty acids. J Pharmacol Exp Ther
n-3 (omega-3) fatty acid levels with lipoproteins: negative correlation 2014;351:688-98.
with HDL-C after an oral load. Nutrafods 2013;12:13-6. 101. Hoshi T, Wissuwa B, Tian Y, Tajima N, Xu R, Bauer M, Heinemann
85. Raposo HF, Patrício PR, Simões MC, Oliveira HC. Fibrates and fish SH, Hou S. Omega-3 fatty acids lower blood pressure by directly
oil, but not corn oil, up-regulate the expression of the cholesteryl ester activating large-conductance Ca2+-dependent K+ channels. Proc Natl
transfer protein (CETP) gene. J Nutr Biochem 2014;25:669-74. Acad Sci U S A 2013;110:4816-21.
86. Chan D, Watts GF, Nguyen MN, Barrett PH. Factorial study of 102. Wakle-Prabagaran M, Lorca RA, Ma X, Stamnes SJ, Amazu C, Hsiao
the effect of n-3 fatty acid supplementation and atorvastatin on the JJ, Karch CM, Hyrc KL, Wright ME, England SK. BKCa channel
kinetics of HDL apolipoproteins A-I and A-II in men with abdominal regulates calcium oscillations induced by alpha-2-macroglobulin in
obesity. Am J Clin Nutr 2006;84:37-43. human myometrial smooth muscle cells. Proc Natl Acad Sci U S A
87. Ooi E, Lichtenstein A, Millar J, Diffenderfer M, Lamon-Fava 2016;113:2335-44.
S, Rasmussen H, Welty FK, Barrett PH, Schaefer EJ. Effects of 103. Novgorodtseva TP, Karaman YK, Gvozdenko TA, Antonyuk MV,
therapeutic lifestyle change diets high and low in dietary fish-derived Knyshova VV. Modification of fatty acids composition in erythrocytes
FAs on lipoprotein metabolism in middle-aged and elderly subjects. J lipids in arterial hypertension associated with dyslipidemia. Health
Lipid Res 2012;53:1958-67. 2013;5:73-7.
88. Fialkow J. Omega-3 fatty acid formulations in cardiovascular disease: 104. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. Plasma
dietary supplements are not substitutes for prescription products. Am fatty acid composition is associated with the metabolic syndrome and
J Cardiovasc Drugs 2016;16:229-39. low-grade inflammation in overweight adolescents. Am J Clin Nutr
89. Mason R, Sherratt S, Jacob R. Eicosapentaenoic acid inhibits 2005;82:1178-84.
oxidation of ApoB-containing lipoprotein particles of different size 105. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM.
in vitro when administered alone or in combination with atorvastatin Effects of n-3 polyunsaturated fatty acids on left ventricular function
active metabolite compared with other triglyceride-lowering agents. J and functional capacity in patients with dilated cardiomyopathy. J Am
Cardiovasc Pharmacol 2016;68:33-40. Coll Cardiol 2011;57:870-9.
90. Borow K, Nelson J, Mason R. Biologic plausibility, cellular effects, 106. del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW,
and molecular mechanisms of eicosapentaenoic acid (EPA) in Gwathmey JK, Rosenzweig A, Hajjar RJ. Restoration of contractile
atherosclerosis. Atherosclerosis 2015;242:357-66. function in isolated cardiomyocytes from failing human hearts by
91. Yamada N, Shames DM, Stoudemire JB, Havel RJ. Metabolism of gene transfer of SERCA2a. Circulation 1999;100:2308-11.
lipoproteins containing apolipoprotein B-100 in blood plasma of 107. Ribeiro Junior RF, Fernandes AA, Meira EF, Batista PR, Siman FD,
rabbits: heterogeneity related to the presence of apolipoprotein E. Vassallo DV, Padilha AS, Stefanon I. Soybean oil increases SERCA2a
Proc Natl Acad Sci U S A 1986;83:3479-83. expression and left ventricular contractility in rats without change in
92. Fernandez ML, McNamara DJ. Dietary fat-mediated changes arterial blood pressure. Lipids Health Dis 2010;9:53.
in hepatic apoprotein B/E receptor in the guinea pig: effect of 108. Liu J, Conklin S, Manuck S, Yao J, Muldoon M. Long-chain omega-3
polyunsaturated, monounsaturated, and saturated fat. Metabolism fatty acids and blood pressure. Am J Hypertens 2011;24:1121-6.
1989;38:1094-102. 109. McLennan P. Myocardial membrane fatty acids and the antiarrhythmic
93. McInnes GT. Lowering blood pressure for cardiovascular risk actions of dietary fish oil in animal models. Lipids 2001;36:S111-4.
reduction. J Hypertens Suppl 2005;23:S3-8. 110. Mori T, Bao D, Burke V, Puddey I, Beilin J. Docosahexaenoic acid
94. Huang T, Shou T, Cai N, Wahlqvist ML, Li D. Associations of plasma but not eicosapentaenoic acid lowers ambulatory blood pressure and
n-3 polyunsaturated fatty acids with blood pressure and cardiovascular heart rate in humans. Hypertension 1999;34:253-60.
risk factors among Chinese. Int J Food Sci Nutr 2012;63:667-73. 111. Tsuburaya R, Yasuda S, Ito Y, Shiroto T, Gao J, Ito K, Shimokawa
95. Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. H. Eicosapentaenoic acid reduces ischemic ventricular fibrillation
Vessel Plus ¦ Volume 1 ¦ September 26, 2017 127